Technology Disclosure. Following Merck making a Pre-Clinical Development Candidate Designation with respect to a Licensed Product, Mersana will disclose and make available to Merck such Mersana Know-How and Mersana Platform Know-How as is necessary or useful to enable Merck to use and reference the Mersana Technology, Mersana Platform Technology and Mersana Regulatory Documentation to practice the applicable Exclusive License on the terms, and subject to the conditions, of this Agreement, including for the Exploitation of ADCs and Licensed Products. [***].
Technology Disclosure. Full disclosure of all engineering and process designs will be made available to the Licensee throughout the term of the agreement.
Technology Disclosure. 4.9.1 Within [***] days after Initiation of the first [***] Clinical Trial, each Party at its own cost and expense shall make available to the other Party, in a format reasonably acceptable to both Parties, Know-How included in the Mersana Technology or Licensee Technology, as applicable, that is necessary or useful for Development of Licensed Products in the Field worldwide, and for Commercialization of Licensed Products in the Field in the territory of the other Party. Through the meetings of the Joint Committees, each Party shall update the other Party on any Know-How that becomes included in the Mersana Technology or Licensee Technology, as applicable and as is necessary or useful for Development of Licensed Products in the Field worldwide, and for Commercialization of Licensed Products in the Field in the territory of the other Party. Following such updates, upon request from a Party, the other Party shall make such Know-How available to the requesting Party, in a format reasonably acceptable to both Parties, within [***] days of such request.
Technology Disclosure. As soon as reasonably practicable following the Effective Date, and from time to time during the Term upon the reasonable request of Licensee, SGI shall deliver to Licensee, in such form as may reasonably be requested by Licensee from time to time, the SGI Know-How as is necessary or reasonably useful to enable Licensee to manufacture or have manufactured and use the Drug Conjugation Materials and the ADCs as provided in this Agreement, including, without limitation, available written or electronic information relating to the [***]. During the Term, upon Licensee’s reasonable request, SGI will provide Licensee, or such Affiliate of Licensee as [***] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. may be designated by Licensee, with assistance and training regarding the manufacture and/or use of Drug Conjugation Materials and ADCs; provided that if in-person assistance is required, such assistance shall take place upon at least [***] prior written notice to SGI at SGI’s facilities, unless otherwise mutually agreed upon. Licensee shall pay to SGI for such assistance an amount equal to the Personnel Fees in accordance with Section 6.1.2 for SGI employees providing such assistance.
Technology Disclosure. Microsoft will, as it determines is appropriate to the implementation of this Agreement, use commercially reasonable efforts to disclose to divine future product and technology directions.
Technology Disclosure. As soon as reasonably practicable following the Effective Date, and from time to time during the Term upon the reasonable request of Licensee, SGI shall deliver to Licensee, in such form as may reasonably be requested by Licensee from time to time, the SGI Know-How as is necessary or reasonably useful to enable Licensee to manufacture or have manufactured and use the Drug Conjugation Materials and the ADCs as provided in this Agreement, including, without limitation, available written or electronic information relating to the [*]. During the Term, upon Licensee’s reasonable request, SGI will provide Licensee, or such Affiliate of Licensee as may be designated by Licensee, with assistance and training regarding the manufacture and/or use of Drug Conjugation Materials and ADCs; provided that if in-person assistance is required, such assistance shall take place upon at least [*] prior written notice to SGI at SGI’s facilities, unless otherwise mutually agreed upon. Licensee shall pay to SGI for such assistance an amount equal to the Personnel Fees in accordance with Section 6.1.2 for SGI employees providing such assistance. [*] CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION
Technology Disclosure. (a) Any party to this Agreement may request a meeting with any other party or parties for the purpose of disclosing or receiving the disclosure of VOLUNTARY DISCLOSURE INFORMATION relating to an identified area of technology. No party shall be required to either disclose or receive the disclosure of VOLUNTARY DISCLOSURE INFORMATION. The meeting request shall state that it has been approved by a Senior R&D Official of the requesting party and shall be addressed to the Senior R&D official of the other party or parties, with a copy to the General Counsel of the other party or parties. The request shall identify the area of technology to be discussed and an Administrator for each area of technology to be discussed. The receiving R&D Official shall approve or deny the meeting request and, if approved, shall identify the Administrator for that party. No meeting may be held without the approval of the respective Senior R&D officials, which must be provided either in writing or in electronic form. The party disclosing VOLUNTARY DISCLOSURE INFORMATION shall send the Administrator a written summary of the substance of the VOLUNTARY Table of Contents
Technology Disclosure. Microsoft shall, as appropriate and for products included within the Microsoft Enterprise Solutions Platform and for other products Microsoft and Banyan mutually agree are important to the Parties' implementation of this Agreement, on a semi- annual basis disclose to Banyan future product and technology directions. As available, Microsoft will provide to Banyan beta releases for products included within the Microsoft Enterprise Solutions Platform and for other products Microsoft and Banyan mutually agree are important to the Parties' implementation of this Agreement. Banyan acknowledges and agrees that Microsoft's obligations under this Section 3.6 are subject to Microsoft's sole determination that disclosure of such information and/or providing such beta releases is appropriate.
Technology Disclosure. FROM POWERDSINE TO MOTOROLA: ---------------------------- . ** REDACTED TABLE FROM MOTOROLA TO POWERDSINE: ** REDACTED TABLE KEY RON DEVELOPMENT MILESTONES: ------------------------------------------------------------------------------ SUBJECT DATE ------------------------------------------------------------------------------ ** REDACTED TABLE RON SPECIFICATIONS FILES: ** REDACTED TABLE MOTOROLA CUSTXX RON for POWERDSINE __________PROGRAM FUNCTIONAL DESCRIPTION RON DESIGN SPECIFICATIONS AND PERFORMANCE REQUIREMENTS EXHIBIT 4 RON IC DESIGN CHANGE REQUEST DATE OF REQUEST: POWERDSINE: ------------------------ ---------------------------- RON IC NO. CHANGE NO. ------------------------------ ----------------------------- DESCRIPTION OF CHANGE: -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ATTACHMENTS SUPPORTING THE REQUESTED CHANGE:
Technology Disclosure. Within each quarterly report referred to in Section 4.2, or more frequently if requested by the JDC or either Party, each Party shall disclose to the other Party in writing any Collaboration IP.
